Dabrosin C

Fulvestrant-Mediated Attenuation of the Innate Immune Response Decreases ER+ Breast Cancer Growth In Vivo More Effectively than Tamoxifen.

Abrahamsson A, Rodriguez GV, Dabrosin C

Cancer Res. 80 (20) 4487-4499 [2020-10-15; online 2020-08-27]

NGI Uppsala (Uppsala Genome Center) [Service] National Genomics Infrastructure [Service]